Editorial: acute inflammation in obesity: IL-17A in the middle of the battle.
Galgani
Mario
M
Matarese
Giuseppe
G
D000208:Acute Disease; D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D004032:Diet / Q000009:adverse effects; D005260:Female; D006801:Humans; D007113:Immunity, Innate; D007249:Inflammation / Q000209:etiology / Q000503:physiopathology*; D020381:Interleukin-17 / Q000502:physiology*; D020738:Leptin / Q000172:deficiency / Q000502:physiology; D051379:Mice; D008820:Mice, Obese; D009504:Neutrophils / Q000378:metabolism; D009765:Obesity / Q000150:complications / Q000235:genetics / Q000503:physiopathology*; D010538:Peritonitis / Q000139:chemically induced / Q000150:complications; D015054:Zymosan / Q000633:toxicity
C508717:IL17A protein, human; C098680:Il17a protein, mouse; D020381:Interleukin-17; D020738:Leptin; D015054:Zymosan